Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,144 | 10,216 | 10,111 | 3,762 | 4,277 |
| Marketable Securities | N/A | N/A | 5,742 | 23,877 | 26,127 |
| Receivables | N/A | N/A | 600 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 428 | 0 |
| TOTAL | $4,955 | $11,073 | $17,783 | $29,744 | $32,371 |
| Non-Current Assets | |||||
| PPE Net | 922 | 1,144 | 1,348 | 1,548 | 5,496 |
| Other Non-Current Assets | 4,262 | 4,681 | 4,994 | 5,342 | 5,673 |
| TOTAL | $5,184 | $5,825 | $6,342 | $6,890 | $11,169 |
| Total Assets | $10,139 | $16,898 | $24,125 | $36,634 | $43,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 13,537 | 15,000 | 15,000 | 15,000 | 14,768 |
| Accounts payable and accrued liabilities | 2,467 | 1,798 | 1,520 | 1,359 | 1,566 |
| Accrued Expenses | 2,091 | 2,636 | 2,285 | 2,073 | 1,867 |
| TOTAL | $19,144 | $20,623 | $20,130 | $19,891 | $20,211 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 2,229 | 5,921 | 9,613 | 13,537 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 600 |
| Other Non-Current Liabilities | 5,470 | 7,731 | 8,897 | 10,412 | 9,956 |
| TOTAL | $2,968 | $5,428 | $9,344 | $13,250 | $17,554 |
| Total Liabilities | $22,112 | $26,051 | $29,474 | $33,141 | $37,765 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 121,512 | 71,869 | 57,542 | 57,482 | 57,289 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | -122,275 | -116,863 | -110,171 | -102,907 | -93,960 |
| Other shareholders' equity | -4,110 | -3,575 | -2,291 | 1,506 | 2,663 |
| TOTAL | $-11,973 | $-9,153 | $-5,349 | $3,493 | $5,775 |
| Total Liabilities And Equity | $10,139 | $16,898 | $24,125 | $36,634 | $43,540 |